Back
Editas Medicine Vs. Scholar Rock Holding Industry Stock Comparison
Sell
41
EDIT
Editas Medicine
Last Price:
2.21
Seasonality Move:
13.73%
Buy
100
SRRK
Scholar Rock Holding
Last Price:
37.04
Seasonality Move:
10.12%
Sell
41
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $2.38. The Score for EDIT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Scholar Rock Holding (SRRK)
is a Buy
Is Scholar Rock Holding a Buy, Sell or Hold?
- The current Scholar Rock Holding [SRRK] share price is $37.72. The Score for SRRK is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- SRRK is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $2.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
SRRK Stock Price Chart
What is Scholar Rock Holding's stock price today?
-
The Scholar Rock Holding share price today is $37.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRRK is experiencing selling pressure, which indicates risk of future bearish movement.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 31.96 | Sell |
| Chaikin Money Flow: | -3498554 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.6 - 3.24) | Sell |
| Bollinger Bands (100): | (2.94 - 4.74) | Sell |
SRRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 74.99 | Buy |
| Chaikin Money Flow: | -5009875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.64 - 31.02) | Buy |
| Bollinger Bands (100): | (6.08 - 25.5) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.5 | Sell |
| 20-day SMA: | 2.84 | Sell |
| 50-day SMA: | 3.18 | Sell |
| 200-day SMA: | 5.19 | Sell |
| 8-day EMA: | 2.53 | Sell |
| 20-day EMA: | 2.78 | Sell |
| 50-day EMA: | 3.17 | Sell |
| 200-day EMA: | 4.95 | Sell |
SRRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.8 | Buy |
| 20-day SMA: | 28.71 | Buy |
| 50-day SMA: | 22.69 | Buy |
| 200-day SMA: | 14.55 | Buy |
| 8-day EMA: | 30.11 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 23.91 | Buy |
| 200-day EMA: | 15.95 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and an increase next year of $0.38 per share.
Scholar Rock Holding Earnings Growth & SRRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.56 per share, and an increase next year of $0.25 per share.
Editas Medicine Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Scholar Rock Holding Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||